H. E. BOSTANCI Et Al. , "New benzimidazole derivatives containing hydrazone group as anticancer agents: Inhibition of carbonic anhydrase IX and molecular docking studies," Archiv der Pharmazie , vol.358, no.3, 2025
BOSTANCI, H. E. Et Al. 2025. New benzimidazole derivatives containing hydrazone group as anticancer agents: Inhibition of carbonic anhydrase IX and molecular docking studies. Archiv der Pharmazie , vol.358, no.3 .
BOSTANCI, H. E., Yıldız, M. T., KAPANCIK, S., ŞAHİN İNAN, Z. D., Kılıç, H. A., ÖZENSOY GÜLER, Ö., ... ACAR ÇEVİK, U.(2025). New benzimidazole derivatives containing hydrazone group as anticancer agents: Inhibition of carbonic anhydrase IX and molecular docking studies. Archiv der Pharmazie , vol.358, no.3.
BOSTANCI, HAYRANİ Et Al. "New benzimidazole derivatives containing hydrazone group as anticancer agents: Inhibition of carbonic anhydrase IX and molecular docking studies," Archiv der Pharmazie , vol.358, no.3, 2025
BOSTANCI, HAYRANİ E. Et Al. "New benzimidazole derivatives containing hydrazone group as anticancer agents: Inhibition of carbonic anhydrase IX and molecular docking studies." Archiv der Pharmazie , vol.358, no.3, 2025
BOSTANCI, H. E. Et Al. (2025) . "New benzimidazole derivatives containing hydrazone group as anticancer agents: Inhibition of carbonic anhydrase IX and molecular docking studies." Archiv der Pharmazie , vol.358, no.3.
@article{article, author={HAYRANİ EREN BOSTANCI Et Al. }, title={New benzimidazole derivatives containing hydrazone group as anticancer agents: Inhibition of carbonic anhydrase IX and molecular docking studies}, journal={Archiv der Pharmazie}, year=2025}